AJP - The American Journal of Pathology

The American Journal of Pathology (AJP) is the leading global forum for reporting quality original research on cellular and molecular mechanisms of disease. Impact Factor: 5.770*

AJP is the official journal of the American Society for Investigative Pathology (ASIP) and published by Elsevier, Inc., seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome.  High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches. Case reports typically do not meet the criteria for inclusion.

Author Benefits

The American Journal of Pathology is the most cited journal in the field of Research Pathology.

• 2021 impact factor: 5.770*
• 2021 5-year impact factor: 5.480
• 2021 Eigenfactor: 0.01428
• 2021 CiteScore: 8.6
• Article downloads in 2021: 1,919,604
• Article citations in 2021: 45,158 (most cited Pathology journal)
• Online Manuscript Submission with Editorial Manager.
• Articles in Press - advance publication online before print
• Authors entitled to 1 FREE electronic reprint
• New Discounts for Authors! ASIP Regular Members receive an author-discount on publication charges and NO color charge!
• Indexed in all major indexing services (NLM's MEDLINE/PubMed, Thomson's Science Scitation, EMBASE, SCOPUS.

Reader Benefits

• Published monthly in print and online at https://ajp.amjpathol.org
• Editorial Board includes internationally recognized leaders in disease investigation
• Reviews, Mini-Reviews, and Biological Perspectives - a blend of key data from the past and current critical discoveries providing insight into future research trends
• Multi-disciplinary research articles featuring the latest advances in every area of disease pathogenesis
• Free online access to all legacy content (12 months or older)
• Free email alerts of new content as it becomes available

*Thomson Reuters Citation Report 2021